Metabolic Conditions

News Watch

“You are not human, you are a walking bacterial colony,” says the Belgian researcher Jeroen Raes, from the Flanders Institute of Biology, in this video from TEDxBrussels. Raes discusses issues that go from the gut microbiota’s size to its functions, as well as its relationship with some of the most prevalent diseases, such as diabetes and obesity. A video that…

GMFH Editing Team
GMFH Editing Team

“You are not human, you are a walking bacterial colony,” says the Belgian researcher Jeroen Raes, from the Flanders Institute of Biology, in this video from TEDxBrussels. Raes discusses issues that go from the gut microbiota’s size to its functions, as well as its relationship with some of the most prevalent diseases, such as diabetes and obesity. A video that…

GMFH Editing Team
GMFH Editing Team

Gastric bypass surgery has been revealed as an effective method for fighting morbid obesity, as this kind of intervention usually leads to a significant weight loss. Until now, scientists were not aware of the important role of the gut microbiota in the positive effects of this treatment. According to a recent study published in Science Translational Medicine, the intervention could…

GMFH Editing Team
GMFH Editing Team

Gastric bypass surgery has been revealed as an effective method for fighting morbid obesity, as this kind of intervention usually leads to a significant weight loss. Until now, scientists were not aware of the important role of the gut microbiota in the positive effects of this treatment. According to a recent study published in Science Translational Medicine, the intervention could…

GMFH Editing Team
GMFH Editing Team

L-carnitine, a chemical compound widely present in red meat (and also some energy drinks), alters the composition of gut microbiota, leading to a potentially increased risk of heart disease. A study carried out by researchers at Cleveland Clinic (United States) has shown that the change in the bacteria living in the digestive tract leads to an increase in a compound…

GMFH Editing Team
GMFH Editing Team

L-carnitine, a chemical compound widely present in red meat (and also some energy drinks), alters the composition of gut microbiota, leading to a potentially increased risk of heart disease. A study carried out by researchers at Cleveland Clinic (United States) has shown that the change in the bacteria living in the digestive tract leads to an increase in a compound…

GMFH Editing Team
GMFH Editing Team

Research & Practice

Gut microbiota dysbiosis has been associated with the onset of several immune- and metabolic-related disorders. The specific role of exogenous factors leading to dysbiosis is still under investigation, and the primary factors contributing to gut microbiome dysbiosis and ultimately to human disease are not clear. A new study, led by Dr. Boakai K. Robertson from the Department of Biological Sciences…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Gut microbiota dysbiosis has been associated with the onset of several immune- and metabolic-related disorders. The specific role of exogenous factors leading to dysbiosis is still under investigation, and the primary factors contributing to gut microbiome dysbiosis and ultimately to human disease are not clear. A new study, led by Dr. Boakai K. Robertson from the Department of Biological Sciences…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

A recent study led by Dr. Luis Fontana (Department of Biochemistry and Molecular Biology II and Institute of Nutrition and Food Technology “José Mataix”, University of Granada, Granada, Spain) has found that administration of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 may downregulate gut inflammatory genes in obese rats. Rats were divided into various…

GMFH Editing Team
GMFH Editing Team

A recent study led by Dr. Luis Fontana (Department of Biochemistry and Molecular Biology II and Institute of Nutrition and Food Technology “José Mataix”, University of Granada, Granada, Spain) has found that administration of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 may downregulate gut inflammatory genes in obese rats. Rats were divided into various…

GMFH Editing Team
GMFH Editing Team

Previous research has shown the aging process and frailty may be associated with a perturbed gut microbiome in elderly people. Indeed, gut microbes could be a major driver of age-associated inflammation in mice, and specific microbial signatures of healthy aging have been previously reported in long-lived individuals. However, it is still unknown whether targeting gut microbes can be effective in…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Previous research has shown the aging process and frailty may be associated with a perturbed gut microbiome in elderly people. Indeed, gut microbes could be a major driver of age-associated inflammation in mice, and specific microbial signatures of healthy aging have been previously reported in long-lived individuals. However, it is still unknown whether targeting gut microbes can be effective in…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

It is well-known that medications could affect the microbiome and therefore host-microbiota interactions are considered a confounding factor that can contribute to therapeutic and side effects of drug treatments. Previous research has shown that gut microbiota may partially mediate both therapeutic and adverse effects of metformin, which is the most prescribed drug for the treatment of individuals with type 2…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

It is well-known that medications could affect the microbiome and therefore host-microbiota interactions are considered a confounding factor that can contribute to therapeutic and side effects of drug treatments. Previous research has shown that gut microbiota may partially mediate both therapeutic and adverse effects of metformin, which is the most prescribed drug for the treatment of individuals with type 2…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

For those seeking the latest science on gut health and its applications to clinical practice, Paris was the place to be on March 11th and 12th, 2017. At the 6th GMFH World Summit, over 400 professionals from all over the world met to review the past decade of advances in gut microbiota science and where the field is headed in…

GMFH Editing Team
GMFH Editing Team

For those seeking the latest science on gut health and its applications to clinical practice, Paris was the place to be on March 11th and 12th, 2017. At the 6th GMFH World Summit, over 400 professionals from all over the world met to review the past decade of advances in gut microbiota science and where the field is headed in…

GMFH Editing Team
GMFH Editing Team